Global Pharmacovigilance market 2013 2019

Transparency Market Research Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Published Date 28-Feb-2014

159 Page Report

Buy Now

Request Sample

Press Release Pharmacovigilance Market: Drive by Pharmaceutical Companies to Mitigate Risk Associated with Drugs to Bolster Growth Transparency Market Research State Tower, 90, State Street, Suite 700.

Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com

Pharmacovigilance Market

REPORT DESCRIPTION

Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 According to “Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019�, a new research study by U.S.-based market research and intelligence firm Transparency Market Research, the global pharmacovigilance market that was valued at US$2,147.3 million in 2012 is estimated to be worth US$5,008.2 million by the end of 2019, growing at a CAGR of 12.9% during the forecast period from 2013 to 2019.

Browse the full report at http://www.transparencymarketresearch.com/pharmacovigilance-market.html Stringent government regulations, issues pertaining to public safety, toughened inspection regimes, coupled with the need of patients to report ailments immediately, has propelled growth in the global pharmacovigilance market. The World Health Organization (WHO) defines pharmacovigilance as the science and activities which help detect, monitor, assess, and evaluate chances of any adverse occurrence or drug-related side effect from the consumption of the medicinal products. Pharmacovigilance activities are aimed to promote safer administration of drugs and other medicinal products. This is attained by generating awareness about the importance of timely, relevant, and precise clinical safety information related to medical products.

The global pharmaceutical industry is growing at a rapid pace and this has led to the innovation of a number of medicinal products that promote faster and more accurate treatment to several diseases and disorders. This range of new medicinal products comes along with many benefits, but none of these benefits are free from adverse drug reactions that can result in illness, disability and at times even death.

Hence, early discovery of adverse drug reactions during clinical trials, clinical phase IV, or during postmarketing surveillance is very important in mitigating the risk of any unpleasant occurrences.

A majority of pharmaceutical companies nowadays are actively involved in assessing and monitoring drugs which are under clinical trial. In fact, new medicinal products that are marketed are also kept under vigilance by the companies. Apart from drugs, medicinal products such as traditional medicines, vaccines,

Transparency Market Research

2

Pharmacovigilance Market

medical devices, and blood products are also assessed and monitored during the different phases of their production and marketing.

We are currently offering a flat 15% discount on all purchases until end of the March 2015! http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1729 The report has segmented the global pharmacovigilance market based on service providers, clinical trial phases and methods used for reporting drug safety. On the basis of clinical trial phases, the global market for pharmacovigilance can be categorized into pre-clinical studies, phase I, phase II, phase III, phase IV, and post-marketing surveillance. Among these segments, clinical trial phase IV accounted for almost 74.7% of the market share in 2012. The market for clinical trial phase IV in 2012 was valued at US$1,604.8 million.

Geographically, North America dominated the global pharmacovigilance market in 2012, however market trends indicate that Asia Pacific will register the highest rate of growth, a CAGR of 15.2%, during the forecast period from 2013 to 2019. Factors such as growing population, reduction in healthcare cost, and high patient enrollment will bolster demand for pharmacovigilance in the global market.

According to the publication, key players dominating the market includes companies such as Cognizant Technology Solutions, Pharmaceutical Product Development Inc. (PPD), Pfizer Inc., Novartis International AG, Accenture, Plc, Parexel International Corporation, Icon Plc., Quintiles Transnational Corporation, PRA International Inc., Bristol-Myers Squibb, Covance Inc., iGATE Corporation, and Wipro Limited.

Browse Full Press Release @ http://www.transparencymarketresearch.com/pressrelease/pharmacovigilance-market.htm

TABLE OF CONTENT

Chapter 1 Introduction 1.1 Report Description 1.2 Research Methodology 1.3 Market Segmentation

Transparency Market Research

3

Pharmacovigilance Market

Chapter 2 Executive Summary

Chapter 3 Global Pharmacovigilance Market Dynamics 3.1 Introduction 3.1.1 Drivers 3.1.1.1 Rise in number of drug consumption 3.1.1.2 Rise in drug toxicity cases producing significant morbidity and mortality 3.1.1.3 Embracing new technologies to mitigate risk 3.1.1.4 Rise in adoption of pharmacovigilance outsourcing services 3.1.1.5 Globalization of drug development with shift from manufacturing activities from high cost to low cost regions 3.1.2 Restraints 3.1.2.1 Stringent and varied regulatory approval processes 3.1.3 Challenges 3.1.3.1 Lack of availability of skilled labor 3.2 Porter’s Five Force Analysis: Global Pharmacovigilance Market 3.2.1 Bargaining Power of Suppliers 3.2.2 Bargaining Power of Buyers 3.2.3 Threat of New Entrants 3.2.4 Threat of Substitutes 3.2.5 Competitive Rivalry 3.3 Market Attractiveness Analysis of the Global Pharmacovigilance Market, by Geography 3.3.1 Market Attractiveness Analysis: Global Pharmacovigilance Market, 2012, by Geography

Transparency Market Research

4

Pharmacovigilance Market

Chapter 4 Global Pharmacovigilance Market, by Clinical Trial Phases 4.1 Overview 4.1.1 Preclinical Studies 4.1.1.1 Global Preclinical Studies Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million) 4.1.2 Phase I trial 4.1.2.1 Global Clinical Trial Phase I Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million) 4.1.3 Phase II trial 4.1.3.1 Global Clinical Trial Phase II Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million) 4.1.4 Phase III trial 4.1.4.1 Global Clinical Trial Phase III Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million) 4.1.5 Phase IV trial (Post marketing surveillance) 4.1.5.1 Global Clinical Trial Phase IV Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million)

Chapter 5 Global Pharmacovigilance Market, By Type of Methods 5.1 Overview 5.1.1 Spontaneous Reporting 5.1.1.1 Global Spontaneous Drug Safety Reporting Market Revenue, 2011 – 2019 (USD Million) 5.1.2 Targeted Reporting 5.1.2.1 Global Targeted Drug Safety Reporting Market Revenue, 2011 – 2019 (USD Million) 5.1.3 Cohort Event Monitoring 5.1.3.1 Global Cohort Event Monitoring Market Revenue, 2011 – 2019 (USD Million)

Transparency Market Research

5

Pharmacovigilance Market

5.1.4 EHR Monitoring 5.1.4.1 Global Electronic Health Records (EHR) Monitoring Market Revenue, 2011 – 2019 (USD Million) 5.1.5 Intensified ADR Reporting 5.1.5.1 Global Intensified ADR Reporting Market Revenue, 2011 – 2019 (USD Million)

Chapter 6 Global Pharmacovigilance Market, by Type of Service Providers 6.1 Overview 6.1.1 In-House 6.1.1.1 Global In-House Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million) 6.1.2 Contract Outsourcing 6.1.2.1 Global Contract Outsourcing Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million)

Chapter 7 Global Pharmacovigilance Market, by Geography 7.1 Overview 7.1.1 Comparative Analysis: Global Pharmacovigilance Market, by Geography, 2012 & 2019 (Value %) 7.2 North America 7.2.1 North America Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million) 7.3 Europe 7.3.1 Europe Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million) 7.4 Asia Pacific 7.4.1 Asia-Pacific Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million) 7.5 Rest of the World 7.5.1 Rest of the World Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million)

Transparency Market Research

6

Pharmacovigilance Market

Chapter 8 Global Pharmacovigilance Market Share Analysis 8.1 Market Share Analysis by Key Players of Global Pharmacovigilance Market 8.1.1 Global CRO Market Share Analysis, by Key Players, 2012 (%)

Chapter 9 Recommendations 9.1 Success Strategies 9.1.1 Developing Strategic Alliances and Partnerships With CROs and Life Science BPOs Companies 9.1.2 Hub and Spoke model to optimize drug safety 9.1.3 Enhancing operational activities for better outcomes 9.1.4 Expand Market into Emerging Countries

Chapter 10 Company Profiles 10.1 Accenture, Plc 10.1.1 Company Overview 10.1.2 Financial Overview 10.1.3 Product Portfolio 10.1.4 Business Strategies 10.1.4.1 Mergers and acquisitions 10.1.5 Recent Developments 10.2 Bristol-Myers Squibb 10.2.1 Company Profile 10.2.2 Financial overview 10.2.3 Product Portfolio

Transparency Market Research

7

Pharmacovigilance Market

10.2.4 Business Strategies 10.2.4.1 Strategic collaboration 10.2.4.2 Research and Development Initiatives 10.2.4.3 Recent Developments 10.3 Clinquest Group B.V. 10.3.1 Company Overview 10.3.2 Product Portfolio 10.3.3 Business Strategies 10.3.3.1 Strategic partnership 10.3.4 Recent Developments 10.4 Cognizant Technology Solutions 10.4.1 Company Overview 10.4.2 Financial Overview 10.4.3 Product Portfolio 10.4.4 Business Strategies 10.4.4.1 Expansion of geographical footprint 10.4.4.2 Expansion of product portfolio 10.4.4.3 Highly-skilled manpower 10.4.4.4 Strategic acquisitions 10.4.5 Recent Developments 10.5 Covance, Inc. 10.5.1 Company Overview 10.5.2 Financial Overview 10.5.3 Product Portfolio

Transparency Market Research

8

Pharmacovigilance Market

10.5.4 Business Strategies 10.5.4.1 New product development and innovation 10.5.4.2 Agreements and collaborations 10.5.4.3 Strategic acquisitions 10.5.4.4 Geographical expansion of business 10.5.5 Recent Developments 10.6 GlaxoSmithKline (GSK) 10.6.1 Company Overview 10.6.2 Financial overview 10.6.3 Product Portfolio 10.6.4 Business strategies 10.6.4.1 Research and development initiatives 10.6.4.2 Direct to Consumer Advertising 10.6.4.3 Mergers and acquisitions 10.6.5 Recent developments 10.7 ICON, Plc 10.7.1 Company Overview 10.7.2 Financial Overview 10.7.3 Product Portfolio 10.7.4 Business Strategies 10.7.4.1 Business expansion in APAC region 10.7.4.2 Expansion of services offered 10.7.5 Recent Developments 10.8 iGATE Corporation

Transparency Market Research

9

Pharmacovigilance Market

10.8.1 Company Overview 10.8.2 Financial Overview 10.8.3 Product Portfolio 10.8.4 Business Strategies 10.8.4.1 Strategic Acquisition 10.8.5 Recent Developments 10.9 iMEDGlobal Corporation 10.9.1 Company Overview 10.9.2 Product Portfolio 10.9.3 Business Strategies 10.9.3.1 Geographical Expansion 10.9.4 Recent Developments 10.10 Infosys 10.10.1 Company Overview 10.10.2 Financial Overview 10.10.3 Product Portfolio 10.10.4 Business Strategies 10.10.4.1 Extensive product portfolio 10.10.4.2 Geographical expansion of business 10.10.5 Recent Developments 10.11 inVentiv Health Inc. 10.11.1 Company Overview 10.11.2 Product Portfolio 10.11.3 Business Strategies

Transparency Market Research

10

Pharmacovigilance Market

10.11.3.1 Strategic Partnership 10.11.3.2 Strategic Acquisition 10.11.4 Recent Developments 10.12 Johnson and Johnson 10.12.1 Company Profile 10.12.2 Financial Overview 10.12.3 Product Portfolio 10.12.4 Business Strategies 10.12.4.1 Extensive Research and Development Investments 10.12.4.2 Strategic Collaborative Arrangements 10.12.4.3 Recent Developments 10.13 Novartis International AG 10.13.1 Company Overview 10.13.2 Financial Overview 10.13.3 Product Portfolio 10.13.4 Business Strategy 10.13.4.1 Mergers and Acquisitions 10.13.5 Recent Developments 10.14 OptumInsight, Inc. 10.14.1 Company Overview 10.14.2 Product Portfolio 10.14.3 Business Strategies 10.14.3.1 Strategic product launch 10.14.3.2 Strategic collaboration

Transparency Market Research

11

Pharmacovigilance Market

10.14.4 Recent Developments 10.15 Parexel International Corporation 10.15.1 Company Overview 10.15.2 Financial Overview 10.15.3 Product Portfolio 10.15.3.1 Strong presence in Asia and emerging markets 10.15.3.2 Strategic alliances 10.15.3.3 Mergers & Acquisitions 10.15.4 Recent Developments 10.16 Pfizer, Inc. 10.16.1 Company Overview 10.16.2 Financial Overview 10.16.3 Product Portfolio 10.16.4 Business Strategies 10.16.4.1 Acquisitions 10.16.5 Recent Developments 10.17 Pharmaceutical Product Development, Inc. (PPD, Inc.) 10.17.1 Company Overview 10.17.2 Product Portfolio 10.17.3 Business Strategies 10.17.3.1 Expanding geographic presence 10.17.3.2 Incorporation of innovative technologies 10.17.3.3 Strategic acquisitions 10.17.3.4 New product launch and innovation

Transparency Market Research

12

Pharmacovigilance Market

10.17.4 Recent Developments 10.18 PRA International, Inc. 10.18.1 Company Overview 10.18.2 Product Portfolio 10.18.3 Business Strategies 10.18.3.1 Mergers and acquisitions 10.18.4 Recent Developments 10.19 Quantum Solutions India 10.19.1 Company Overview 10.19.2 Product Portfolio 10.19.3 Business Strategies 10.19.3.1 Strategic Collaborations 10.20 Quintiles Transnational Corporation 10.20.1 Company Overview 10.20.2 Financial Overview 10.20.3 Product Portfolio 10.20.4 Business Strategies 10.20.4.1 Expansion of services 10.20.4.2 Acquisitions and partnerships 10.20.4.3 Innovation in services offered 10.20.5 Recent Developments 10.21 F. Hoffmann-La Roche Ltd. 10.21.1 Company Overview 10.21.2 Financial Overview

Transparency Market Research

13

Pharmacovigilance Market

10.21.3 Product Portfolio 10.21.4 Business Strategies 10.21.4.1 Licensing Agreement 10.21.4.2 Product portfolio expansion 10.22 Sanofi Aventis 10.22.1 Company Overview 10.22.2 Financial Overview 10.22.3 Product Portfolio 10.22.4 Business Strategy 10.22.4.1 Renewal of cooperation protocol 10.22.4.2 Recent developments 10.23 Synowledge LLC 10.23.1 Company Overview 10.23.2 Product Portfolio 10.23.3 Business Strategies 10.23.3.1 Geographical Expansion 10.23.3.2 Strategic Partnership 10.23.4 Recent Developments 10.24 United BioSource Corporation 10.24.1 Company Overview 10.24.2 Product Profiling 10.24.3 Business Strategies 10.24.3.1 Strategic acquisitions 10.25 Wipro Limited

Transparency Market Research

14

Pharmacovigilance Market

10.25.1 Company Overview 10.25.2 Financial Overview 10.25.3 Product Portfolio 10.25.4 Business Strategies 10.25.4.1 Geographical expansion

Browse More Report on Healthcare IT Market @ http://www.transparencymarketresearch.com/healthcareit-market-reports-19.html

About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers.

Contact

Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Browse The Market Research Blog : https://marketsresearchindustry.wordpress.com/

Transparency Market Research

15